Milk Thistle (Silymarin) Dosage for Specific Liver Conditions: An Evidence-Based Guide
Review of clinical evidence on silymarin dosing for hepatitis C, NASH, alcoholic liver disease, and decompensated cirrhosis, including bioavailability and safet
Review of clinical evidence on silymarin dosing for hepatitis C, NASH, alcoholic liver disease, and decompensated cirrhosis, including bioavailability and safet
Evidence-based review of milk thistle allergic reactions, case reports, and silymarin’s immunomodulatory effects. Covers Asteraceae sensitivity considerations.
Milk thistle’s silymarin has notoriously low bioavailability. Here’s the pharmacokinetic reason why, and what phospholipid, SMEDDS, and cocrystal formulas try t
A clear, evidence-based look at milk thistle’s side effects, who should be cautious, and drug interactions to know before taking silymarin.
A look at what’s known and unknown about milk thistle (silymarin) safety during pregnancy and lactation, including galactagogue claims.
Research on taking milk thistle with statins like simvastatin or rosuvastatin, and why the interaction is nuanced.
What the clinical research actually shows about milk thistle’s timeline, dosing windows, and why liver markers respond at different speeds.
How milk thistle (silymarin) affects CYP450 liver enzymes and P-glycoprotein, which medications are most likely affected, and what the evidence actually shows.
A practical, evidence-aware guide to milk thistle (silymarin) dosing, forms, timing, and what the research does and doesn’t support.